| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6157196 | American Journal of Kidney Diseases | 2015 | 6 Pages |
Abstract
Elevated levels of PAI-1 appearance rates are present in patients who develop EPS, pointing to progressive peritoneal fibrosis and sclerosis. The PAI-1 appearance rate has fair discriminative capacity from 3 years prior to EPS diagnosis. Therefore, effluent PAI-1 may aid in monitoring peritoneal fibrosis and serve as a biomarker for EPS.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Deirisa PhD, Dirk G. MD, PhD, Raymond T. MD, PhD,